Recent Activity

Loading...

PCRX

Pacira Biosciences, Inc. · NASDAQ

Performance

+3.22%

1W

+14.7%

1M

+5.98%

3M

+10.27%

6M

-8.65%

YTD

-23.81%

1Y

Profile

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Investment Analysis Report: PCRX

Overview

PCRX is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $1.35 billion. The company's financial data provides insights into its valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow, and capital exp...

See more ...

Technical Analysis of PCRX 2024-05-10

Overview:

In analyzing the technical indicators for PCRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day MA has been showing an upward trend, indicating a pos...
See more ...

Recent News & Updates